Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 7.84 Billion | USD 45.46 Billion | 21.6% | 2023 |
The global gene synthesis market size was worth around USD 7.84 billion in 2023 and is predicted to grow to around USD 45.46 billion by 2032 with a compound annual growth rate (CAGR) of roughly 21.6% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the gene synthesis market on a global and regional level.
Gene synthesis is a synthetic biological procedure conducted via in vitro conditions. In gene synthesis, the DNA is duplicated or synthesized with various chemicals. Gene synthesis provides flexibility to the engineered and synthesized target sequences for any kind of downstream application. Unlike DNA replication that occurs in cells or by the use of PCR (Polymerase Chain Reaction), gene synthesis doesn’t require an initial template strand to start the replication process.
The rising number of R&D activities associated with gene synthesis is mainly fueling the growth of the global gene synthesis market. The increasing investments made by leading companies and government of developing countries in gene synthesis, introduction of new and cost-effective gene synthesis technology, growing awareness about the treatment for genetically inherited diseases, and rising prominence of clinical research to understand biological systems at their core molecular levels are some other factors also fueling the global gene synthesis market.
The study provides a decisive view of the gene synthesis market by segmenting it on the basis of method, type, component, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
By method, the gene synthesis market includes oligonucleotides and gene assembly. The oligonucleotide segment is sub-segmented into ion semiconductor sequencing, high-throughput array-based gene synthesis technology, phosphoramidite reaction cycle, and nanopore sequencing. Gene assembly segment is further divided into polymerase-based (PCR, OE, polymerase cycling assembly, TBIO, microchip-based multiplex gene synthesis, and others), ligase-based (shotgun ligation, two-step ligation and PCR, ligase chain reaction, and brick-based), and recombinant-based (transformation-associated recombination, SLIC, and biobrick assembly).
The type segment is divided into custom library synthesis and gene library synthesis. The custom gene synthesis is further sub-segmented into customized coding sequences, RNAi constructs, genomic DNA, cDNA, and others.
Based on component, the market is bifurcated into product and services.
Based on application, the market includes research and development, therapeutics, diagnosis, and others.
Report Attributes | Report Details |
---|---|
Report Name | Gene Synthesis Market |
Market Size in 2023 | USD 7.84 Billion |
Market Forecast in 2032 | USD 45.46 Billion |
Growth Rate | CAGR of 21.6% |
Number of Pages | 110 |
Key Companies Covered | ATDBio, ATUM, Bioneer Corporation, BioCat, Blue Heron Biotech, Biomatik, Epoch Life Science, GENEWIZ, Eurofins Genomics, Integrated DNA Technologies, Genscript, Kaneka Eurogentec, ProteoGenix, OriGene Technologies, Shanghai Medicilon, Thermo Fisher Scientific, Synbio Technologies, and Vigene Biosciences |
Segments Covered | By Method, By Type, By Component, By Application and By region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.
By region, North America is expected to dominate the global gene synthesis market in the future, due to the increasing awareness about the growing prevalence of gene-related diseases, rising research on the treatment of these diseases, and the presence of highly developed research infrastructure. The Asia Pacific gene synthesis market is projected to show the highest growth rate in the upcoming years, owing to the growing investments made by companies and government in gene synthesis research, rising number of biopharmaceutical establishments and biotechnology companies, and increasing numbers of gene tests for the diagnosis of gene-related diseases.
Some key players in the global gene synthesis market are:
Global Gene Synthesis Market: Method Analysis
Global Gene Synthesis Market: Type Analysis
Global Gene Synthesis Market: Component Analysis
Global Gene Synthesis Market: Application Analysis
Global Gene Synthesis Market: Regional Analysis
FrequentlyAsked Questions
Gene synthesis is a laboratory technique that involves artificially creating DNA sequences, including entire genes, without the need for natural DNA templates.
According to study, the Gene Synthesis market size was worth around USD 7.84 billion in 2023 and is predicted to grow to around USD 45.46 billion by 2032.
The CAGR value of Gene Synthesis market is expected to be around 21.6% during 2024-2032.
North America has been leading the Gene Synthesis market and is anticipated to continue on the dominant position in the years to come.
The Gene Synthesis market is led by players like ATDBio, ATUM, Bioneer Corporation, BioCat, Blue Heron Biotech, Biomatik, Epoch Life Science, GENEWIZ, Eurofins Genomics, Integrated DNA Technologies, Genscript, Kaneka Eurogentec, ProteoGenix, OriGene Technologies, Shanghai Medicilon, Thermo Fisher Scientific, Synbio Technologies, and Vigene Biosciences.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed